In the Journals

Reduced efficacy from repeat flu vaccination depends on vaccine type, strain

February 20, 2019
Repeat immunization with inactivated influenza vaccine appears to reduce children’s antibody responses to influenza strains A(H1N1)pdm09 and B…

In the JournalsPerspective

Recombinant zoster vaccine offers better value, protection against shingles

February 18, 2019
Vaccination with the recombinant zoster vaccine demonstrated higher cost-effectiveness and prevention of herpes zoster, compared with live zoster…

In the Journals

CDC includes ‘homelessness’ as indication for hepatitis A vaccine

February 15, 2019
The CDC recently announced that all persons aged 1 year or older experiencing homelessness should be routinely immunized for hepatitis A, based on a…

Hand-to-genital contact unlikely to cause HPV transmission

February 15, 2019
HPV transmission is unlikely to occur from hand-to-genital contact, and most infections are caused by genital-to-genital sexual transmission…

Meeting News

Vaccination, antiviral treatment fails to affect stroke risk from herpes zoster

February 15, 2019
Contracting herpes zoster increased risk for acute ischemic stroke, and among patients with herpes zoster, vaccination or antiviral treatment did not…

In the Journals

Work-related infectious diseases most common in certain industries

February 13, 2019
Cases of work-related infectious disease in the United States are concentrated in certain industries and occupations, particularly among health care…

In the Journals

Mandatory screening helped stop TB outbreak among Atlanta homeless

February 13, 2019
A comprehensive public health approach that included mandatory screening helped stop an outbreak of drug-resistant tuberculosis in Atlanta homeless…

In the Journals

BCG vaccine scars tied to decline in infant mortality

February 13, 2019
Scarring caused by bacillus Calmette-Guérin, or BCG, vaccine in both mothers and infants was associated with a significant decrease in infant…

In the Journals

PD-1 blockade may increase risk for, severity of TB infection

February 13, 2019
A type of cancer immunotherapy may increase the risk for and severity of tuberculosis infection, according to a recent report. The outcomes of two…

In the Journals

ALT flares in HBV low, linked to seroconversion in untreated patients

February 11, 2019
Among patients with chronic hepatitis B, the cumulative incidence of severe alanine aminotransferase flares was low and correlated with decreased HBV…

Oxford signs deal with US startup to develop universal flu vaccine

February 10, 2019
The University of Oxford announced that it has signed a deal to develop a universal influenza vaccine candidate with Blue Water Vaccines, a United…

Meeting News

Patients with IBD receive suboptimal preventive care consultations

February 10, 2019
LAS VEGAS — Despite existing guidelines for preventive care in patients with inflammatory bowel disease, providers fell short of expectations…

Measles cases in Europe tripled in 2018, WHO says

February 7, 2019
Nearly 83,000 cases of measles were reported in Europe last year — more than triple the amount reported in 2017 and 15 times as many cases as…

In the Journals

PCV13 reduces CAP in France more than 5 years later

February 6, 2019
Vaccination with the 13-valent pneumococcal conjugate vaccine has consistently decreased the rate of community-acquired pneumonia among French…

In the Journals

LAIV added to immunization schedule

February 5, 2019
The childhood and adolescent immunization recommendations for 2019 have been updated to include the use of a live-attenuated intranasal influenza…

In the Journals

ACIP updates adult immunization schedule for influenza, HAV, HBV

February 4, 2019
The Advisory Committee on Immunization Practices released its 2019 immunization schedule for adults aged 19 years and older, including new or revised…

Breaking News

Many cases in DRC Ebola outbreak coming from health centers

February 1, 2019
Six months into the 10th and largest Ebola virus outbreak in the Democratic Republic of the Congo, or DRC, officials said many confirmed cases are…

FDA News

FDA approves 0.5 mL Fluzone for young children

January 31, 2019
The FDA approved the 0.5 mL dose of Fluzone, a quadrivalent influenza vaccine, for use in children aged between 6 and 35 months. The manufacturer…

In the Journals

Investigational Ebola treatment yields positive results in phase 1 trial

January 30, 2019
MAb114, an investigational Ebola treatment, is safe, well tolerated, and easy to administer, according to results from an early-stage clinical trial…

Dicerna completes first dosing in phase 1 trial of RNA-based HBV therapy

January 29, 2019
Dicerna Pharmaceuticals announced the dosing of the first volunteer in a phase 2 clinical trial of DCR-HBVS, the company’s investigational…